A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Clinical trial NCT00399802 · COMPLETED

Trial details

NCT number: NCT00399802
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Bone Disease

Start date: 2006-11-16
Primary completion: 2007-12-05
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.